Stoke Therapeutics (STOK) Short Interest Ratio & Short Volume $9.42 +0.24 (+2.63%) Closing price 03:59 PM EasternExtended Trading$9.44 +0.02 (+0.25%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Stoke Therapeutics Short Interest DataStoke Therapeutics (STOK) has a short interest of 12.84 million shares. This marks a 2.23% increase in short interest from the previous month. The short interest ratio (days to cover) is 14.9, indicating that it would take 14.9 days of the average trading volume of 710,399 shares to cover all short positions.Current Short Interest12,840,000 sharesPrevious Short Interest12,560,000 sharesChange Vs. Previous Month+2.23%Dollar Volume Sold Short$125.32 millionShort Interest Ratio14.9 Days to CoverLast Record DateApril 30, 2025Outstanding Shares54,597,000 sharesPercentage of Shares Shorted23.52%Today's Trading Volume319,706 sharesAverage Trading Volume710,399 sharesToday's Volume Vs. Average45% Short Selling Stoke Therapeutics? Sign up to receive the latest short interest report for Stoke Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSTOK Short Interest Over TimeSTOK Days to Cover Over TimeSTOK Percentage of Float Shorted Over Time Stoke Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202512,840,000 shares $125.32 million +2.2%N/A14.9 $9.76 4/15/202512,560,000 shares $97.34 million +3.9%26.7%14.5 $7.75 3/31/202512,090,000 shares $80.40 million +3.3%25.7%13.5 $6.65 3/15/202511,710,000 shares $100.71 million +4.8%24.9%13.9 $8.60 2/28/202511,170,000 shares $87.68 million +10.7%23.8%14.1 $7.85 2/15/202510,090,000 shares $107.76 million +12.2%21.5%12.9 $10.68 1/31/20258,990,000 shares $103.21 million +2.7%N/A12.4 $11.48 1/15/20258,750,000 shares $83.04 million +17.0%N/A13.5 $9.49 12/31/20247,480,000 shares $82.50 million +3.0%N/A12.1 $11.03 12/15/20247,260,000 shares $87.56 million +7.9%N/A12.3 $12.06 Get the Latest News and Ratings for STOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Stoke Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20246,730,000 shares $81.50 million +5.2%N/A11.1 $12.11 11/15/20246,400,000 shares $76.99 million -4.5%N/A11.6 $12.03 10/31/20246,700,000 shares $82.81 million -1.3%N/A12.7 $12.36 10/15/20246,790,000 shares $86.17 million -2.7%N/A12.7 $12.69 9/30/20246,980,000 shares $85.78 million -19.9%N/A12.7 $12.29 9/15/20248,710,000 shares $126.03 million -5.8%N/A14.4 $14.47 8/31/20249,250,000 shares $134.59 million -6.5%N/A15.4 $14.55 8/15/20249,890,000 shares $140.93 million +0.7%N/A15.2 $14.25 7/31/20249,820,000 shares $147.01 million -4.7%N/A13.6 $14.97 7/15/202410,300,000 shares $150.17 million +8.8%N/A13 $14.58 6/30/20249,470,000 shares $127.94 million +13.3%N/A11 $13.51 6/15/20248,360,000 shares $135.85 million +1.7%N/A5.5 $16.25 5/31/20248,220,000 shares $120.18 million +3.9%N/A5.7 $14.62 5/15/20247,910,000 shares $111.77 million -4.8%N/A5.8 $14.13 4/30/20248,310,000 shares $91.66 million +50.3%N/A6.6 $11.03 4/15/20245,530,000 shares $67.52 million +11.7%N/A4.8 $12.21 3/31/20244,950,000 shares $66.83 million +39.4%15.0%4.9 $13.50 3/15/20243,550,000 shares $22.68 million -5.6%12.8%6.3 $6.39 2/29/20243,760,000 shares $29.10 million -5.3%13.5%16.7 $7.74 2/15/20243,970,000 shares $21.08 million -3.9%14.3%18.2 $5.31 1/31/20244,130,000 shares $19.99 million +20.1%14.8%20.6 $4.84 1/15/20243,440,000 shares $17.61 million +3.6%12.4%16.4 $5.12 12/31/20233,320,000 shares $17.46 million +4.1%11.9%14.7 $5.26 12/15/20233,190,000 shares $16.33 million -20.7%11.5%14 $5.12 11/30/20234,020,000 shares $15.24 million -1.5%14.5%18.6 $3.79 11/15/20234,080,000 shares $18.81 million -5.3%14.7%21 $4.61 10/31/20234,310,000 shares $16.42 million -4.7%15.9%19.1 $3.81 10/15/20234,520,000 shares $18.51 million -1.7%16.7%11.3 $4.10 9/30/20234,600,000 shares $18.12 million -3.6%17.0%11.3 $3.94 9/15/20234,770,000 shares $23.75 million +3.0%16.5%11.9 $4.98F1 Engineering Powers This Electric Marine Motor (Ad)The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.How one NASDAQ-listed disruptor is bringing the world's most powerful electric marine powertrain to 8/31/20234,630,000 shares $26.02 million +3.8%16.0%10.7 $5.62 8/15/20234,460,000 shares $24.84 million -18.9%15.4%10.1 $5.57 7/31/20235,500,000 shares $36.52 million -3.7%19.1%13.3 $6.64 7/15/20235,710,000 shares $57.96 million -0.2%19.9%17.4 $10.15 6/30/20235,720,000 shares $60.80 million +4.8%19.9%23.5 $10.63 6/15/20235,460,000 shares $70.60 million +4.4%19.0%21.2 $12.93 5/31/20235,230,000 shares $58.58 million +7.2%18.2%23.3 $11.20 5/15/20234,880,000 shares $57.29 million +3.6%17.0%20.8 $11.74 4/30/20234,710,000 shares $41.87 million +20.8%16.4%20.2 $8.89 4/15/20233,900,000 shares $31.86 million -8.7%13.6%13.4 $8.17 3/31/20234,270,000 shares $35.57 million +8.4%15.9%14.7 $8.33 3/15/20233,940,000 shares $36.05 million +1.3%14.7%12 $9.15 2/28/20233,890,000 shares $34.58 million No Change14.5%11.9 $8.89 2/15/20233,890,000 shares $35.05 million +1.8%16.3%12.1 $9.01 1/31/20233,820,000 shares $38.05 million -1.0%16.0%9.5 $9.96 1/15/20233,860,000 shares $37.64 million +0.5%16.2%11.4 $9.75 12/30/20223,840,000 shares $35.44 million +6.7%16.1%10.8 $9.23 12/15/20223,600,000 shares $29.88 million -1.6%15.1%11.1 $8.30 11/30/20223,660,000 shares $27.60 million -13.3%16.7%11.2 $7.54 11/15/20224,220,000 shares $42.16 million -8.1%19.2%13.3 $9.99 10/31/20224,590,000 shares $68.16 million -10.9%21.1%19.5 $14.85 10/15/20225,150,000 shares $61.34 million -5.5%23.7%22.5 $11.91 9/30/20225,450,000 shares $69.98 million +3.6%25.0%25 $12.84 9/15/20225,260,000 shares $86.74 million -1.5%24.2%24.5 $16.49 8/31/20225,340,000 shares $80.42 million +1.9%27.0%23.5 $15.06 8/15/20225,240,000 shares $112.40 million -3.3%26.5%21.2 $21.45 7/31/20225,420,000 shares $80.16 million -7.2%27.6%18.5 $14.79 7/15/20225,840,000 shares $88.18 million -3.2%29.7%20 $15.10 6/30/20226,030,000 shares $79.66 million +1.9%30.7%20.8 $13.21 6/15/20225,920,000 shares $63.40 million +0.5%30.1%18 $10.71 5/31/20225,890,000 shares $71.33 million +1.9%30.0%18.4 $12.11 5/15/20225,780,000 shares $86.06 million -6.3%29.4%18.3 $14.89 4/30/20226,170,000 shares $89.09 million -0.2%34.6%19.7 $14.44 4/15/20226,180,000 shares $125.70 million +6.4%34.7%18.2 $20.34 3/31/20225,810,000 shares $122.30 million +8.6%33.0%16.3 $21.05 3/15/20225,350,000 shares $108.82 million +25.3%30.4%16.7 $20.34 2/28/20224,270,000 shares $83.27 million +17.0%24.6%14.3 $19.50 2/15/20223,650,000 shares $70.70 million +0.3%21.0%12.3 $19.37 1/31/20223,640,000 shares $68.98 million +17.4%20.2%13.5 $18.95 1/15/20223,100,000 shares $60.70 million +12.7%15.6%12.5 $19.58 12/31/20212,750,000 shares $65.97 million +1.9%N/A14.1 $23.99 12/15/20212,700,000 shares $54.41 million +10.7%13.6%14.7 $20.15 11/30/20212,440,000 shares $60.76 million -0.8%12.3%14.6 $24.90 11/15/20212,460,000 shares $70.33 million +21.8%12.4%17.3 $28.59 10/29/20212,020,000 shares $46.12 million +7.5%10.2%17.4 $22.83 10/15/20211,880,000 shares $44.22 million -5.1%9.5%16.1 $23.52 9/30/20211,980,000 shares $50.37 million +28.6%10.0%16.4 $25.44 9/15/20211,540,000 shares $37.13 million -0.7%7.8%11.1 $24.11 8/31/20211,550,000 shares $40.58 million +6.2%7.8%11.8 $26.18 8/13/20211,460,000 shares $37.57 million +5.0%7.4%9.8 $25.73F1 Engineering Powers This Electric Marine Motor (Ad)The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.How one NASDAQ-listed disruptor is bringing the world's most powerful electric marine powertrain to 7/30/20211,390,000 shares $39.80 million -32.2%7.0%8.8 $28.63 7/15/20212,050,000 shares $67.67 million -12.0%10.4%12.1 $33.01 6/30/20212,330,000 shares $78.43 million -4.1%N/A12.2 $33.66 6/15/20212,430,000 shares $89.13 million -10.3%12.8%13 $36.68 5/28/20212,710,000 shares $107.48 million -11.7%14.3%14 $39.66 5/14/20213,070,000 shares $102.48 million +2.7%16.2%15.8 $33.38 4/30/20212,990,000 shares $100.73 million -5.1%15.8%15.3 $33.69 4/15/20213,150,000 shares $108.08 million -0.3%16.7%17.1 $34.31 3/31/20213,160,000 shares $117.08 million +10.5%16.8%19.8 $37.05 3/15/20212,860,000 shares $146.60 million -13.3%15.2%17.3 $51.26 2/26/20213,300,000 shares $193.18 million -2.1%17.5%21.9 $58.54 2/12/20213,370,000 shares $207.76 million -3.2%17.9%21.1 $61.65 1/29/20213,480,000 shares $215.79 million +0.9%18.8%21.4 $62.01 1/15/20213,450,000 shares $225.35 million -2.8%18.6%21.6 $65.32 12/31/20203,550,000 shares $213.25 million +19.5%19.5%23.8 $60.07 12/15/20202,970,000 shares $166.44 million +0.7%16.3%21.8 $56.04 11/30/20202,950,000 shares $150.95 million +3.9%16.2%24.5 $51.17 11/15/20202,840,000 shares $127.77 million -0.7%16.5%24.9 $44.99 10/30/20202,860,000 shares $113.86 million -1.0%18.1%33.1 $39.81 10/15/20202,890,000 shares $111.53 million +1.8%18.3%33.1 $38.59 9/30/20202,840,000 shares $95.11 million +1.4%18.0%27.3 $33.49 9/15/20202,800,000 shares $91.59 million +1.1%17.7%23.6 $32.71 8/31/20202,770,000 shares $81.35 million +3.4%17.5%21.5 $29.37 8/14/20202,680,000 shares $77.72 million +3.9%17.0%20 $29.00 7/31/20202,580,000 shares $64.99 million +3.2%16.5%18.5 $25.19 7/15/20202,500,000 shares $58.13 million -29.6%16.0%18.5 $23.25 6/30/20203,550,000 shares $84.60 million +13.4%22.9%25.2 $23.83 6/15/20203,130,000 shares $70.55 million +2.6%20.2%20.6 $22.54 5/29/20203,050,000 shares $82.08 million +0.7%19.7%16.3 $26.91 STOK Short Interest - Frequently Asked Questions What is Stoke Therapeutics' current short interest? Short interest is the volume of Stoke Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 12,840,000 shares of STOK short. Learn More on Stoke Therapeutics' current short interest. What is a good short interest ratio for Stoke Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. STOK shares currently have a short interest ratio of 15.0. Learn More on Stoke Therapeutics's short interest ratio. Which institutional investors are shorting Stoke Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Stoke Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Stoke Therapeutics' short interest increasing or decreasing? Stoke Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 12,840,000 shares, an increase of 2.2% from the previous total of 12,560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Stoke Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Stoke Therapeutics: Vericel Co. (9.18%), NewAmsterdam Pharma (8.68%), Belite Bio, Inc (0.23%), Harmony Biosciences Holdings, Inc. (7.46%), Denali Therapeutics Inc. (9.34%), Kymera Therapeutics, Inc. (11.03%), Kiniksa Pharmaceuticals, Ltd. (4.56%), CG Oncology, Inc. (24.37%), Tarsus Pharmaceuticals, Inc. (19.78%), Galapagos NV (2.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Stoke Therapeutics stock? Short selling STOK is an investing strategy that aims to generate trading profit from Stoke Therapeutics as its price is falling. STOK shares are trading up $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Stoke Therapeutics? A short squeeze for Stoke Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STOK, which in turn drives the price of the stock up even further. How often is Stoke Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STOK, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Vericel Short Interest NewAmsterdam Pharma Short Interest Belite Bio Short Interest Harmony Biosciences Short Interest Denali Therapeutics Short Interest Kymera Therapeutics Short Interest Kiniksa Pharmaceuticals Short Interest CG Oncology Short Interest Tarsus Pharmaceuticals Short Interest Galapagos Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:STOK) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | SponsoredThe biggest threat isn’t ChinaWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy STOK Stock Free STOK Stock Alerts